121 related articles for article (PubMed ID: 36591801)
1. GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERα signaling.
Tang HL; Wang Q; Lu JG; Yang XJ; Shi JJ; Wang SP; Cao CQ; Zhao HD
Neoplasma; 2022 Dec; 69(6):1386-1395. PubMed ID: 36591801
[TBL] [Abstract][Full Text] [Related]
2. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
Yang H; Yu N; Xu J; Ding X; Deng W; Wu G; Li X; Hou Y; Liu Z; Zhao Y; Xue M; Yu S; Wang B; Li X; Niu G; Wang H; Zhu J; Zhuang T
J Exp Clin Cancer Res; 2018 Feb; 37(1):24. PubMed ID: 29433542
[TBL] [Abstract][Full Text] [Related]
3. GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression.
Fang Z; Zhu Z; Zhang H; Peng Y; Liu J; Lu H; Li J; Liang L; Xia S; Wang Q; Fu B; Wu K; Zhang L; Ginzburg Y; Liu J; Chen H
Br J Haematol; 2020 Jan; 188(2):321-331. PubMed ID: 31418854
[TBL] [Abstract][Full Text] [Related]
4. SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion.
Kwon A; Lee HL; Woo KM; Ryoo HM; Baek JH
Mol Cells; 2013 Dec; 36(6):548-55. PubMed ID: 24241683
[TBL] [Abstract][Full Text] [Related]
5. Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promotes Thyroid Cancer Cell Proliferation and Migration via Ubiquitin-Dependent Degradation of Kisspeptin-1.
Yan C; Su H; Song X; Cao H; Kong L; Cui W
Cell Physiol Biochem; 2018; 49(5):2047-2059. PubMed ID: 30244247
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
7. Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.
Liu W; Ip MM; Podgorsak MB; Das GM
Breast Cancer Res Treat; 2009 May; 115(1):43-50. PubMed ID: 18481172
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
Pu Q; Lv YR; Dong K; Geng WW; Gao HD
BMC Cancer; 2020 Jun; 20(1):583. PubMed ID: 32571254
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells.
Katayama H; Sen S
Horm Cancer; 2011 Apr; 2(2):117-24. PubMed ID: 21761334
[TBL] [Abstract][Full Text] [Related]
12. BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer.
Mo Q; Xu K; Luo C; Zhang Q; Wang L; Ren G
Biochem Biophys Res Commun; 2021 May; 553():17-24. PubMed ID: 33756341
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
14. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
Fukunaga E; Inoue Y; Komiya S; Horiguchi K; Goto K; Saitoh M; Miyazawa K; Koinuma D; Hanyu A; Imamura T
J Biol Chem; 2008 Dec; 283(51):35660-7. PubMed ID: 18927080
[TBL] [Abstract][Full Text] [Related]
15. Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.
Gu G; Barone I; Gelsomino L; Giordano C; Bonofiglio D; Statti G; Menichini F; Catalano S; Andò S
J Cell Physiol; 2012 Oct; 227(10):3363-72. PubMed ID: 22213398
[TBL] [Abstract][Full Text] [Related]
16. GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion.
Gerardo-Ramírez M; Lazzarini-Lechuga R; Hernández-Rizo S; Jiménez-Salazar JE; Simoni-Nieves A; García-Ruiz C; Fernández-Checa JC; Marquardt JU; Coulouarn C; Gutiérrez-Ruiz MC; Pérez-Aguilar B; Gomez-Quiroz LE
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1540-1554. PubMed ID: 30890427
[TBL] [Abstract][Full Text] [Related]
17. RUNX1T1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells.
Saikia S; Pal U; Kalita DJ; Rai AK; Sarma A; Kataki AC; Limaye AM
Mol Biol Rep; 2021 Jul; 48(7):5399-5409. PubMed ID: 34264479
[TBL] [Abstract][Full Text] [Related]
18. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
19. p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.
Berger CE; Qian Y; Liu G; Chen H; Chen X
J Biol Chem; 2012 Aug; 287(36):30117-27. PubMed ID: 22787161
[TBL] [Abstract][Full Text] [Related]
20. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
